THE DIFFICULT ANTITHROMBOTIC TREATMENT BALANCE IN A PATIENT WITH ADVANCED HEART FAILURE AND ATRIAL FIBRILLATION: WISELY SAILING BETWEEN SCYLLA AND CHARYBDIS

被引：0
|
作者：
Galati, G.
Pozniak, K.
Margonato, A.
机构：
[1] IRCCS Osped San Raffaele, Milan, Italy
[2] Daiichi Sankyo Italia, Dipartimento Med, Milan, Italy
来源：
EUROPEAN HEART JOURNAL SUPPLEMENTS | 2019年 / 21卷 / 0E期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P116
引用
收藏
页码：E139 / E139
页数：1
相关论文
共 24 条
  • [1] Anticoagulation for atrial fibrillation in heart failure patients: balancing between Scylla and Charybdis
    Tsigkas, Grigorios
    Apostolos, Anastasios
    Despotopoulos, Stefanos
    Vasilagkos, Georgios
    Papageorgiou, Angeliki
    Kallergis, Eleftherios
    Leventopoulos, Georgios
    Mplani, Virginia
    Koniari, Ioanna
    Velissaris, Dimitrios
    Parissis, John
    JOURNAL OF GERIATRIC CARDIOLOGY, 2021, 18 (05) : 352 - 361
  • [2] Anticoagulation for atrial fibrillation in heart failure patients:balancing between Scylla and Charybdis
    Grigorios Tsigkas
    Anastasiοs Apostolos
    Stefanos Despotopoulos
    Georgios Vasilagkos
    Angeliki Papageorgiou
    Eleftherios Kallergis
    Georgios Leventopoulos
    Virginia Mplani
    Ioanna Koniari
    Dimitrios Velissaris
    John Parissis
    Journal of Geriatric Cardiology, 2021, 18 (05) : 352 - 361
  • [3] Antithrombotic treatment differences among hospitalized patients with atrial fibrillation and heart failure
    Samaras, A.
    Michou, E.
    Fotos, G.
    Dividis, G.
    Vasdeki, D.
    Kotsi, E.
    Tsoukra, P.
    Forozidou, E.
    Panagiotidis, T.
    Kartas, A.
    Doundoulakis, I.
    Giannakoulas, G. George
    Karvounis, H.
    Tzikas, A.
    EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 : 251 - 251
  • [4] Treatment of the Heart Failure Patient With Atrial Fibrillation A Major Unmet Need
    Bristow, Michael R.
    Aleong, Ryan G.
    JACC-HEART FAILURE, 2013, 1 (01) : 29 - 30
  • [5] Associations Between Cardiac Fibrosis and Permanent Atrial Fibrillation in Advanced Heart Failure
    Aldhoon, B.
    Kucera, T.
    Smorodinova, N.
    Martinek, J.
    Melenovsky, V.
    Kautzner, J.
    PHYSIOLOGICAL RESEARCH, 2013, 62 (03) : 247 - 255
  • [6] Antithrombotic Treatment in Patients With Heart Failure and Associated Atrial Fibrillation and Vascular Disease A Nationwide Cohort Study
    Lamberts, Morten
    Lip, Gregory Y. H.
    Ruwald, Martin H.
    Hansen, Morten Lock
    Ozcan, Cengiz
    Kristensen, Soren L.
    Kober, Lars
    Torp-Pedersen, Christian
    Gislason, Gunnar H.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (24) : 2689 - 2698
  • [7] Cardiometabolic risk factors and antithrombotic treatment in a Mexican population with atrial fibrillation and heart failure with reduced ejection fraction
    Banos-Gonzalez, Manuel A.
    Gonzalez-Hermosillo, Antonio
    Guevara-Valdivia, Milton E.
    Vazquez-Acosta, Jorge A.
    de los Rios-Ibarra, Manuel O.
    Aguilar-Linares, Julio A.
    Cantu-Brito, Carlos
    Leiva-Pons, Jose L.
    Pozas-Garza, Gerardo
    Favela-Perez, Eddie A.
    Molina, Luis
    Magana-Magana, Reynaldo
    Chuquiure-Valenzuela, Eduardo
    Camacho-Casillas, Rocio
    Manzano-Cabada, Janneth
    Marquez-Murillo, Manlio F.
    GACETA MEDICA DE MEXICO, 2023, 159 (01): : 24 - 31
  • [8] Intravenous amiodarone bolus for treatment of atrial fibrillation in patients with advanced congestive heart failure or cardiogenic shock
    Hofmann, R
    Steinwender, C
    Kammler, J
    Kypta, A
    Wimmer, G
    Leisch, F
    WIENER KLINISCHE WOCHENSCHRIFT, 2004, 116 (21-22) : 744 - 749
  • [9] Intravenous amiodarone bolus for treatment of atrial fibrillation in patients with advanced congestive heart failure or cardiogenic shock
    Mazhar, R.
    JOURNAL FUR KARDIOLOGIE, 2006, 13 : 14 - 14
  • [10] Intravenous amiodarone bolus for treatment of atrial fibrillation in patients with advanced congestive heart failure or cardiogenic shock
    Robert Hofmann
    Clemens Steinwender
    Jürgen Kammler
    Alex Kypta
    Gottfried Wimmer
    Franz Leisch
    Wiener klinische Wochenschrift, 2004, 116 : 744 - 749
123